"MicroRNA Leaves Signature for T1D Nephropathy"
"Patients with type 1 diabetes and nephropathy had a handful of noncoding microRNA molecules -- known as miRNAs -- that were unique to them, researchers reported here." Click here to read the full article Source- http://www.medpagetoday.com/meetingcoverage/nkf/57732 #type1 #nephropathy #news
"Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patient
"Glycated albumin (GA) is a marker for monitoring glycemic control in diabetic patients with end-stage renal disease (ESRD). We evaluated whether serum albumin-adjusted GA ( adjusted GA) could predict mortality in diabetic patients with ESRD on hemodialysis." Click here to read the full article Source- http://www.jdcjournal.com/article/S1056-8727(16)30026-5/abstract http://www.epinex.com/#!glycated-albumin/yrxvx #glycatedalbumin #GlycatedAlbumin #Hemodialysis #nephrology #nep
"Glycated albumin is a better indicator of the glucose excursion than predialysis glucose and h
"GA levels may be a better indicator of glycemic control than HbA1c and pre-dialysis glucose levels, especially as a means of evaluating the glucose excursions in diabetic HD patients." Click here to read the full article Source- http://rrtjournal.biomedcentral.com/articles/10.1186/s41100-016-0013-7 http://www.epinex.com/#!glycated-albumin/yrxvx http://www.epinexdiabetesblog.com/#!Glycated-Albumin-The-Next-A1c/cjds/563a6a670cf28330832d23be #GlycatedAlbumin #glycatedhemoglobin
"Finerenone cuts albuminuria in diabetic nephropathy"
"Adding the mineralocorticoid receptor antagonist finerenone to standard renin-angiotensin system (RAS) blockade decreased albuminuria and improved the urinary albumin/creatinine ratio in an industry-sponsored phase IIB clinical trial of diabetic nephropathy, according to a report published online Sept. 1 in JAMA." Click here to read the full article Source- http://www.clinicalendocrinologynews.com/specialty-focus/diabetes/single-article-page/finerenone-cuts-albuminuria-in-di
"Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic k
"Diabetic nephropathy is the most common aetiology of end-stage kidney disease (ESKD). Strict glycaemic control reduces the development and progression of diabetes-related complications, and there is evidence that improved metabolic control improves outcomes in diabetic subjects with advanced chronic kidney disease (CKD). Glycaemic control in people with kidney disease is complex. Changes in glucose and insulin homeostasis may occur as a consequence of loss of kidney function
